New sleep aid trial targets lingering insomnia in depression
Symptom relief
Terminated
This study tests if Lemborexant, a sleep medication, can improve sleep in adults whose depression is already treated but who still have insomnia. About 30 participants will take either the drug or a placebo daily for 6 weeks, tracking sleep with diaries and a wearable device. The…
Phase: PHASE2 • Sponsor: Unity Health Toronto • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC